-
Necrostatin-1 and the Next Phase of Necroptosis Research
2026-08-17
Necrostatin-1 is more than a pathway inhibitor: it is a strategic tool for separating RIP1 kinase-dependent necroptosis from overlapping regulated cell-death programs. This article connects mechanistic rigor, translational assay design, and emerging ferroptosis biology to guide more reproducible research with Nec-1.
-
MTT Assays: From Mechanism to Translational Strategy
2026-08-17
MTT is more than a routine viability reagent: it is a metabolic readout that can connect molecular perturbations to cellular phenotypes when its chemistry, controls, and limitations are managed deliberately. This article examines MTT in the context of ovarian cancer biology, ERH knockdown, assay validation, competitive positioning, and translational decision-making.
-
Protein A/G Magnetic Beads: Practical Workflow
2026-08-16
Protein A/G Magnetic Beads (SKU K1305) support antibody capture, immunoprecipitation, co-IP, Ch-IP, and antibody purification from complex samples. This guide explains setup, controls, and troubleshooting while noting that the supplied materials contain no directly matched paper evidence and do not establish diagnostic or medical performance.
-
Direct Mouse Genotyping Kit Plus Guide
2026-08-15
The Direct Mouse Genotyping Kit Plus combines direct mouse tissue lysis with PCR amplification and a PCR master mix with dye reagents. Its purification-free lysate-to-PCR workflow supports routine mouse genotyping assay work, transgene detection in mice, gene knockout validation, and animal colony genetic screening.
-
Psora 4: From Channel Block to Assay Design
2026-08-14
Psora 4 is a potent Kv1.3 blocker for mechanistic studies of T-cell excitability, calcium signaling, and effector-memory responses. This article explains how KCNE4-dependent inhibition kinetics should shape assay timing, interpretation, and translation into inflammatory disease models.
-
From Mouse Tail DNA to Translational CRC Insight
2026-08-14
Reliable mouse genotyping is more than a husbandry checkpoint: it is the first quality-control decision in mechanistic and translational research. This article connects rapid genomic DNA release from mouse tissue with Bai et al.’s autophagy–liver metastasis signature in colorectal cancer, offering practical workflow guidance, competitive context, and a cautious path from genotype to clinically relevant biological insight.
-
Novel PDK4 Inhibitors for Metabolic Disease
2026-08-13
This 2019 Journal of Medicinal Chemistry study used anthraquinone-based structural optimization to identify allosteric pyruvate dehydrogenase kinase 4 inhibitors, including compound 8c with nanomolar in vitro activity. The compound improved glucose tolerance in diet-induced obese mice and reduced allergic responses, while docking, pharmacokinetic, and metabolism data supported further PDK4-directed drug discovery.
-
Peroxynitrite, Ca2+ Flux, and Cardiac I/R
2026-08-13
Liu et al. identify an ONOO−–ER stress–IP3R–mitochondrial Ca2+ pathway that links hyperhomocysteinemia with cardiac microvascular endothelial necroptosis during ischemia–reperfusion. The study combines cellular and rat models to show that interrupting IP3R-dependent Ca2+ transfer can improve infarct and cardiac-function outcomes, providing a mechanistic framework for necroptosis and vascular injury research.
-
Mouse Tissue Lysis Kit K1038: Practical Protocol
2026-08-12
The Mouse Tissue Lysis Kit (K1038) prepares lysates from mouse tail, toe, or ear tissue for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and assay development, not diagnostic, clinical, or medical use.
-
Moesin as a Sepsis Endothelial Injury Biomarker
2026-08-12
Chen et al. identify circulating moesin as a candidate biomarker of endothelial injury and sepsis severity, linking serum measurements with SOFA scores, procalcitonin, and experimental lung damage. Their combination of patient data, LPS and CLP models, and endothelial-cell silencing experiments suggests that moesin is associated with Rock1/MLC and NF-κB signaling, although prospective clinical validation is still required.
-
Sodium Dicloxacillin Monohydrate for MSSA Research
2026-08-11
Sodium dicloxacillin monohydrate is a narrow-spectrum β-lactam antibiotic used in research on susceptible Gram-positive bacteria, especially methicillin-sensitive Staphylococcus aureus (MSSA). Its reported activity varies by strain, cellular compartment, and pH, so EC50, MIC, exposure, and assay conditions should be reported separately.
-
Mubritinib (TAK 165) in OXPHOS Research
2026-08-11
Mubritinib (TAK 165) supports a mechanism-first workflow for studying complex I dependence in chemotherapy-resistant AML, while offering a distinct comparison point for HER2 and PEL models. This guide translates published findings into practical dosing, assay-selection, and troubleshooting strategies.
-
Firefly Luciferase mRNA for Reliable Assays
2026-08-10
Learn how Firefly Luciferase mRNA (ARCA, 5-moUTP), SKU R1012, can improve reporter consistency across gene expression, cell viability, and cytotoxicity workflows. This scenario-based guide connects cap chemistry, modified nucleotides, handling, controls, and data interpretation with practical laboratory decisions.
-
Phosphatase Inhibitor Cocktail 2: Workflow Guide
2026-08-09
Phosphatase Inhibitor Cocktail 2 is a 100X aqueous reagent for protein phosphorylation preservation in cellular crude extracts. Its multi-inhibitor formulation supports Western blotting and related phosphoprotein assays, but it does not replace protease control, rapid sample handling, or assay-specific validation.
-
Minocycline HCl in Retinal Microglia Assays
2026-08-08
Explore how Minocycline HCl functions as a mechanistic probe in retinal amyloid-clearance studies, beyond its established antimicrobial activity. This article translates 40-Hz flicker and MHC-II-positive microglia findings into practical assay design, interpretation, and handling decisions.